2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Integrative Oncology: Use of complementary therapies alongside conventional treatments.
Integrative oncology combines evidence-based complementary therapies with conventional cancer treatments to support patients throughout their cancer journey. Practices such as acupuncture, yoga, mind-body techniques, and guided imagery are used alongside standard treatments like chemotherapy and radiation to manage symptoms like pain, fatigue, nausea, and anxiety. The goal is to enhance the body's natural healing processes and improve the patient's overall well-being. Integrative oncology not only helps reduce side effects of treatment but also promotes relaxation, stress reduction, and a greater sense of inner balance. However, it’s essential for patients to work closely with their oncology team to ensure that complementary therapies are safe and do not interfere with their standard treatment protocols. This holistic approach aims to treat the whole person—body, mind, and spirit—throughout their cancer care journey.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China